Avoro Capital Advisors’s Acceleron Pharma XLRN Stock Holding History

Avoro Capital Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,000,000	Closed	-$688M	–	49
2021 Q3	$688M	Buy	4,000,000 +1,000,000	+33%	+$131M	10.81%	3
2021 Q2	$376M	Hold	3,000,000	–	–	6.55%	4
2021 Q1	$407M	Buy	3,000,000 +1,450,000	+94%	+$187M	7.03%	4
2020 Q4	$198M	Buy	1,550,000 +200,000	+15%	+$23.5M	3.42%	10
2020 Q3	$152M	Buy	1,350,000 +310,000	+30%	+$30.9M	2.16%	11
2020 Q2	$99.1M	Buy	1,040,000 +180,000	+21%	+$17.4M	1.96%	17
2020 Q1	$77.3M	Buy	+860,000	New	+$66.8M	2.61%	14

Avoro Capital Advisors's XLRN Position: Q4 2021 in Review

Avoro Capital Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 4,000,000 shares — an estimated $688M sold.

Avoro Capital Advisors first reported a position in XLRN in Q1 2020 and held it in 7 quarters. The position peaked at $688M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Avoro Capital Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Avoro Capital Advisors sold 4,000,000 Acceleron Pharma shares in Q4 2021, an estimated $688M.
Avoro Capital Advisors first reported a position in Acceleron Pharma in Q1 2020 and held it in 7 quarters.
Avoro Capital Advisors's Acceleron Pharma position peaked at $688M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Avoro Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.